MP Materials shares have surged roughly 169% over the past year as investors price in the company’s expanding role in the U.S. rare-earth supply chain. This outperformance reflects growing demand for domestically sourced high-performance magnets by both government and commercial customers, driving the stock to trade at a material premium to peers. Despite this rally, consensus earnings estimates for the next two fiscal years have been revised downward by an average of 12%, signaling that robust top-line growth may not immediately translate into proportional profit expansion.

In 2025 MP secured two cornerstone deals that underpin its forward outlook: a $400 million Department of Defense investment tied to a 10-year floor price of $110 per kilogram for neodymium-praseodymium (NdPr) oxides, and a multiyear, $500 million supply agreement with a leading consumer electronics firm, under which $200 million is prepaid for 100% recycled rare-earth magnets. Together, these contracts guarantee steady demand for magnets produced at the company’s forthcoming 10X Facility and mitigate price volatility in the NdPr market.

MP Materials operates the Mountain Pass mine in California—the only scalable rare-earth production site in the continental U.S.—and has invested heavily in downstream processing. Its magnet manufacturing arm includes an existing plant in Fort Worth, Texas, and the under-construction 10X Facility, which will boost annual magnet output by up to 20,000 metric tons once fully operational. Management forecasts total rare-earth oxide equivalent production to increase by 75% from 2025 levels by mid-2027, positioning the company to meet both military and commercial demand.

Despite a strong strategic position, MP faces significant execution challenges. The ramp-up of new facilities will require substantial capital expenditure, forecast at $350 million over the next 18 months, which could dampen free cash flow in the near term. Moreover, integration of recycled feedstock processes and ensuring consistent product quality at scale remain unproven at full capacity. As a result, MP’s elevated valuation may be vulnerable to setbacks in project timelines or cost overruns, making the stock more suitable for investors with a high risk tolerance.